Neuroliefs, Relivion®

Neurolief's Relivion® Secures Regulatory Approval in Japan, Pioneering At-Home Migraine Treatment

07.08.2025 - 18:07:07 | prnewswire.co.uk

Neurolief Inc. Israel Florida Japan

en | boerse | 67948043 |